GlySign is a research training network on glycomic clinical markers and assay development for Precision Medicine


It is a European Industrial Doctorate and aims at exploiting the translational synergies between excellent academic and industrial partners to the fullest extent and bringing known glycomics markers to the clinic


The GlySign Consortium is composed of three among world-class research centres and companies acting at the forefront of glycomics research and technology development
Final GlySign meeting; February 3-7, 2020